BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36355492)

  • 1. Long-Term Fenofibrate Treatment Stimulates the Phenotypic Microevolution of Prostate Cancer Cells In Vitro.
    Warzecha KW; Pudełek M; Catapano J; Madeja Z; Czyż J
    Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44
    Wróbel T; Luty M; Catapano J; Karnas E; Szczygieł M; Piwowarczyk K; Ryszawy D; Drabik G; Zuba-Surma E; Siedlar M; Madeja Z; Elas M; Czyż J
    Stem Cells; 2020 Sep; 38(12):1544-56. PubMed ID: 32985018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel.
    Luty M; Piwowarczyk K; Łabędź-Masłowska A; Wróbel T; Szczygieł M; Catapano J; Drabik G; Ryszawy D; Kędracka-Krok S; Madeja Z; Siedlar M; Elas M; Czyż J
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30641904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress.
    Catapano J; Luty M; Wróbel T; Pudełek M; Piwowarczyk K; Kędracka-Krok S; Siedlar M; Madeja Z; Czyż J
    Cell Mol Biol Lett; 2022 Nov; 27(1):100. PubMed ID: 36401206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
    Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
    J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.
    Piwowarczyk K; Wybieralska E; Baran J; Borowczyk J; Rybak P; Kosińska M; Włodarczyk AJ; Michalik M; Siedlar M; Madeja Z; Dobrucki J; Reiss K; Czyż J
    Expert Opin Ther Targets; 2015 Feb; 19(2):163-76. PubMed ID: 25389904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.
    Wilk A; Urbanska K; Grabacka M; Mullinax J; Marcinkiewicz C; Impastato D; Estrada JJ; Reiss K
    Cell Cycle; 2012 Jul; 11(14):2660-71. PubMed ID: 22732497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.
    Drukala J; Urbanska K; Wilk A; Grabacka M; Wybieralska E; Del Valle L; Madeja Z; Reiss K
    Mol Cancer; 2010 Jun; 9():159. PubMed ID: 20569465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
    Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
    Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells.
    Binello E; Mormone E; Emdad L; Kothari H; Germano IM
    J Neurooncol; 2014 Apr; 117(2):225-34. PubMed ID: 24493576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
    Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D; Bandyopadhyay A
    Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
    Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
    Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
    Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
    Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression.
    Enright JM; Zhang S; Thebeau C; Siebert E; Jin A; Gadiraju V; Zhang X; Chen S; Semenkovich CF; Rajagopal R
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.
    Gervois P; Kleemann R; Pilon A; Percevault F; Koenig W; Staels B; Kooistra T
    J Biol Chem; 2004 Apr; 279(16):16154-60. PubMed ID: 14764586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.
    Kuno T; Hata K; Takamatsu M; Hara A; Hirose Y; Takahashi S; Imaida K; Tanaka T
    Int J Mol Sci; 2014 May; 15(5):9160-72. PubMed ID: 24857924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
    Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate improves high-fat diet-induced and palmitate-induced endoplasmic reticulum stress and inflammation in skeletal muscle.
    Dai F; Jiang T; Bao YY; Chen GJ; Chen L; Zhang Q; Lu YX
    Life Sci; 2016 Jul; 157():158-167. PubMed ID: 27297630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.